A top administrator at New York’s acclaimed Animal Medical Center is moving into the corporate world as Zoetis Inc.’s executive director and chief medical officer of U.S. Diagnostics.
Richard E. Goldstein, DVM, DACVIM, DECVIM-CA, spent the past six years as the chief medical officer at Animal Medical Center and for 12 years before that was a professor of small animal medicine at the Cornell University College of Veterinary Medicine.
Parsippany, New Jersey-based Zoetis reported Jan. 8 that Dr. Goldstein will lead the U.S. Diagnostics team “in expanding its product portfolio and will spearhead the division’s studies and publishing opportunities.”
In addition, he will work with the U.S. Companion Animal Division to develop educational events for sales and marketing, and he will manage the Key Opinion Leader program.
“His award-winning work, research and passion for preventing genetic and infectious diseases make him an ideal fit for our company,” said Lisa Lee, vice president of U.S. Diagnostics and Business Solutions.
Zoetis, which manufacturers drugs and vaccines for small and large animals, noted that Dr. Goldstein’s research and clinical interests have focused on “improving the ability of veterinarians to detect and prevent genetic and infectious diseases in companion animals through the development of multiple novel diagnostic tests and vaccines.”
“His most significant impact has been in infectious disease through his work on both canine Lyme disease and leptospirosis, for which he has achieved international recognition,” the company added.
Dr. Goldstein, who will start his new job Feb. 5, earned his DVM from the Koret School of Veterinary Medicine at Hebrew University of Jerusalem.